Meiji Yasuda Life Insurance’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $705K | Hold |
5,606
| – | – | 0.02% | 160 |
|
|
2025
Q1 | $620K | Sell |
5,606
-194
| -3% | -$21.5K | 0.01% | 180 |
|
|
2024
Q4 | $792K | Hold |
5,800
| – | – | 0.01% | 162 |
|
|
2024
Q3 | $668K | Hold |
5,800
| – | – | 0.01% | 174 |
|
|
2024
Q2 | $798K | Buy |
5,800
+2,500
| +76% | +$344K | 0.02% | 177 |
|
|
2024
Q1 | $455K | Buy |
+3,300
| New | +$455K | 0.01% | 222 |
|